Literature DB >> 23266604

HIV: so near and yet so far.

Allan R Tenorio1, Alan L Landay.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23266604     DOI： 10.1007/s11904-012-0151-7

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN： 1548-3568            Impact factor:   5.071


× No keyword cloud information.
  14 in total

Review 1.  New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.

Authors:  Christoph Welsch; Arun Jesudian; Stefan Zeuzem; Ira Jacobson
Journal:  Gut       Date:  2012-05       Impact factor: 23.059

2.  Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City.

Authors:  Judith E Sackoff; David B Hanna; Melissa R Pfeiffer; Lucia V Torian
Journal:  Ann Intern Med       Date:  2006-09-19       Impact factor: 25.391

3.  HIV infection and risk for incident pulmonary diseases in the combination antiretroviral therapy era.

Authors:  Kristina Crothers; Laurence Huang; Joseph L Goulet; Matthew Bidwell Goetz; Sheldon T Brown; Maria C Rodriguez-Barradas; Krisann K Oursler; David Rimland; Cynthia L Gibert; Adeel A Butt; Amy C Justice
Journal:  Am J Respir Crit Care Med       Date:  2010-09-17       Impact factor: 21.405

4.  Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection.

Authors:  I Bica; B McGovern; R Dhar; D Stone; K McGowan; R Scheib; D R Snydman
Journal:  Clin Infect Dis       Date:  2001-01-23       Impact factor: 9.079

5.  Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation.

Authors:  Gero Hütter; Daniel Nowak; Maximilian Mossner; Susanne Ganepola; Arne Müssig; Kristina Allers; Thomas Schneider; Jörg Hofmann; Claudia Kücherer; Olga Blau; Igor W Blau; Wolf K Hofmann; Eckhard Thiel
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

6.  Incidence of non-AIDS-defining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression.

Authors:  Roger J Bedimo; Kathleen A McGinnis; Melinda Dunlap; Maria C Rodriguez-Barradas; Amy C Justice
Journal:  J Acquir Immune Defic Syndr       Date:  2009-10-01       Impact factor: 3.731

7.  Inflammation, coagulation and cardiovascular disease in HIV-infected individuals.

Authors:  Daniel A Duprez; Jacqueline Neuhaus; Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Daniel Nixon; Nicholas I Paton; Ronald J Prineas; James D Neaton
Journal:  PLoS One       Date:  2012-09-10       Impact factor: 3.240

8.  Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study.

Authors:  Margaret May; Mark Gompels; Valerie Delpech; Kholoud Porter; Frank Post; Margaret Johnson; David Dunn; Adrian Palfreeman; Richard Gilson; Brian Gazzard; Teresa Hill; John Walsh; Martin Fisher; Chloe Orkin; Jonathan Ainsworth; Loveleen Bansi; Andrew Phillips; Clifford Leen; Mark Nelson; Jane Anderson; Caroline Sabin
Journal:  BMJ       Date:  2011-10-11

9.  Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial.

Authors:  Bertran Auvert; Dirk Taljaard; Emmanuel Lagarde; Joëlle Sobngwi-Tambekou; Rémi Sitta; Adrian Puren
Journal:  PLoS Med       Date:  2005-10-25       Impact factor: 11.069

Review 10.  Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis.

Authors:  Jael Obiero; Peter G Mwethera; Gregory D Hussey; Charles S Wiysonge
Journal:  BMC Infect Dis       Date:  2012-11-06       Impact factor: 3.090
View more
  1 in total

1.  Design, synthesis and evaluation of cytotoxic, antimicrobial, and anti-HIV-1 activities of new 1,2,3,4-tetrahydropyrimidine derivatives.

Authors:  Nima Razzaghi-Asl; Mahsa Kamrani-Moghadam; Behzad Farhangi; Rouhollah Vahabpour; Rezvan Zabihollahi; Saghi Sepehri
Journal:  Res Pharm Sci       Date:  2019-03-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.